Medtronic, davita launch mozarc medical, aimed at introducing new solutions for patients with kidney failure

New, independent kidney health technology company will combine expertise from two industry leaders to drive care transformation dublin and denver , april 1, 2023 /prnewswire/ -- medtronic plc (nyse: mdt) and davita inc. (nyse: dva) today announced the launch of mozarc medical—an independent new company committed to reshaping kidney health and driving patient-centered technology solutions. "mozarc medical's focus will be on meaningful and innovative kidney health technologies that improve the overall patient experience and increase access to care globally," said ven manda, ceo of mozarc medical.
DVA Ratings Summary
DVA Quant Ranking